SEC Tracker
Get the app
SGHT · XBRL financial data

Sight Sciences financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (SGHT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers20,00918,751*19,26521,37020,15719,074*17,50819,56419,90620,385*19,69823,388
Cost of goods and services sold2,6772,776*2,7933,0253,2502,513*2,4142,9772,7092,597*2,7202,014
Gross profit17,33215,975*16,47218,34516,90716,561*15,09416,58717,19717,788*16,97821,374
Research and development4,2393,427*4,6364,3164,7464,293*4,4304,3873,3522,437*2,5462,512
Selling, general and administrative26,50423,658*26,55926,68023,39024,197*24,52323,86721,75019,020*26,84522,750
Total operating expenses30,74327,085*31,19530,99628,13628,490*28,95328,25425,10221,457*29,39125,262
Operating income (loss)(13,411)(11,110)*(14,723)(12,651)(11,229)(11,929)*(13,859)(11,667)(7,905)(3,669)*(12,413)(3,888)
Interest expense1,4321,351*1,2041,1451,1511,161*1,2631,2841,3061,289*1,2681,290
Other income (expense)1,8861,780*(8)(44)26(7)*(139)24(2)(30)*(29)82
Income tax expense (benefit)7810*171516638*4140(79)8*1128
Net income (loss)(13,035)(10,691)*(16,266)(12,329)(11,066)(11,846)*(14,154)(11,941)(8,169)(4,162)*(12,980)(4,446)
Earnings per share, basic USD per share(0.27)(0.22)*(0.33)(0.25)(0.22)(0.23)*(0.28)(0.23)(0.16)(0.08)*(0.24)(0.08)
Earnings per share, diluted USD per share(0.27)(0.22)*(0.33)(0.25)(0.22)(0.23)*(0.28)(0.23)(0.16)(0.08)*(0.24)(0.08)
Weighted average shares, basic thousands of shares48,67148,897*49,48649,90350,34150,797*51,29151,82252,37853,082*53,94354,506
Weighted average shares, diluted thousands of shares48,67148,897*49,48649,90350,34150,797*51,29151,82252,37853,082*53,94354,506

Balance sheet

CSV

Fiscal quarters (SGHT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents144,501138,129127,284118,177118,564120,357108,768101,50092,37391,96584,96279,753
Accounts receivable16,91914,28915,64319,91912,92910,7869,4249,6149,7449,74510,59511,386
Inventory9,2407,8496,8716,7816,0916,3255,8056,2147,9847,7677,0075,695
Prepaid and other current assets2,8992,6042,2911,4522,8852,3062,9092,1033,4943,2573,9484,606
Total current assets173,559162,871152,089146,329140,469139,774126,906119,431113,595112,734106,512101,440
Property and equipment, net1,5561,6401,5501,4891,4481,5801,4851,4601,5451,6101,6181,667
Right-of-use asset8711,4581,2971,2571,1009358176945684381,2021,185
Total assets176,641166,651155,560149,715143,597142,839129,680121,971116,256115,300109,702104,872
Accounts payable3,5351,7311,6661,9231,2971,6912,7652,0761,7421,3431,4861,898
Accrued liabilities2,5501,6393,5703,7722,4472,1132,3693,0642,3672,1402,3532,334
Current portion of long-term debt02,219000000003,79710,131
Total current liabilities14,33112,25211,69313,28813,79915,46812,12211,93611,83111,02718,16320,499
Long-term debt33,76531,70833,69733,77034,15239,35639,58339,82140,06940,30036,73630,645
Lease liability, non-current0914802747614473328183470870804
Total liabilities49,57246,43646,35148,07748,64055,31652,05251,95951,96651,35855,79951,978
Accumulated deficit(284,099)(294,790)(311,056)(323,385)(334,451)(346,297)(360,451)(372,392)(380,561)(384,723)(397,703)(402,149)
Total stockholders' equity127,069120,215109,209101,63894,95787,52377,62870,01264,29063,94253,90352,894
Total liabilities and equity176,641166,651155,560149,715143,597142,839129,680121,971116,256115,300109,702104,872
Common shares outstanding (cover page) thousands of shares48,75049,55349,75650,30750,75551,33351,70252,36752,87254,00654,41055,088

Cash flows

CSV

Fiscal quarters (SGHT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(13,035)(10,691)*(16,266)(12,329)(11,066)(11,846)*(14,154)(11,941)(8,169)(4,162)*(12,980)(4,446)
Stock-based compensation3,856*3,460*4,5064,317*4,308*3,946*4,2433,842*2,420*2,549*2,8532,963*
Depreciation and amortization160*159*192186*158*176*149125*105*108*10394*
Net cash from operating activities(9,828)*(6,484)*(9,786)(9,468)*362*(3,459)*(11,605)(7,543)*(8,719)*(1,827)*(7,029)(5,663)*
Purchases of property and equipment304*264*11780*51*137*0210*170*(156)*6019*
Net cash from investing activities(304)*(264)*(117)(80)*(51)*(137)*0(210)*(170)*156*(60)(19)*
Net cash from financing activities118*376*(942)441*76*5,389*16485*25*1,265*88474*
Net change in cash(10,014)*(6,372)*(10,845)(9,107)*387*1,793*(11,589)(7,268)*(8,864)*(406)*(7,001)(5,208)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Sight Sciences79,75323,388(5,663)*55.1M14.1 quarters 10-QJun 30, 2026
Profound Medical38,2712,483(11,338)*36.5M3.4 quarters 10-QJun 30, 2026
Stereotaxis10,4917,670(3,675)*100.2M2.9 quarters 10-QJun 30, 2026
SkinHealth Systems206,07472,1132,671*130.1M— 10-QJun 30, 2026
Sanara MedTech15,42128,1372,038*9.2M— 10-QJun 30, 2026
Anika Therapeutics38,41232,610(684)*13.4M56.2 quarters 10-QJun 30, 2026
Utah Medical Products87,5288,5291,383*3.2M— 10-QJun 30, 2026
AVITA Medical9,13921,702(3,496)*30.9M3.2 quarters 10-QJun 30, 2026
Lakeland Industries17,90150,139(404)*9.9M— 10-QJul 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.